This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by George, W L Articles by Finegold, S M Search for Related Content PubMed PubMed Citation Articles by George, W L Articles by Finegold, S M

 Previous Article  |  Next Article 

J Clin Microbiol. 1982 June; 15(6): 1049-1053

Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.

ABSTRACT

Fecal specimens from 223 subjects were evaluated for the presence of Clostridium difficile by use of a selective medium developed in our laboratory and for the presence of C. difficile cytotoxin. C. difficile and cytotoxin were detected in 89 and 83%, respectively, of patients with antimicrobial agent-associated pseudomembranous colitis (PMC). In patients in whom PMC was not documented, C. difficile and cytotoxin were present in only 37 and 21%, respectively. C. difficile and cytotoxin were also recovered from the feces of 6 and 3, respectively, of 13 antimicrobial recipients who did not have diarrhea. Although C. difficile appears to be a major cause of PMC, it is not responsible for at least some two-thirds of cases of antimicrobial agent-associated diarrhea in which PMC is not documented. Neither the recovery of C. difficile nor the detection of its cytotoxin should be considered diagnostic for C. difficile-induced disease.

This article has been cited by other articles:

• Hinkson, P. L., Dinardo, C., DeCiero, D., Klinger, J. D., Barker, R. H. Jr. (2008). Tolevamer, an Anionic Polymer, Neutralizes Toxins Produced by the BI/027 Strains of Clostridium difficile. Antimicrob. Agents Chemother. 52: 2190-2195 [Abstract] [Full Text]  
• Baines, S. D., Saxton, K., Freeman, J., Wilcox, M. H. (2006). Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model. J Antimicrob Chemother 58: 1062-1065 [Abstract] [Full Text]  
• Barbut, F., Decre, D., Lalande, V., Burghoffer, B., Noussair, L., Gigandon, A., Espinasse, F., Raskine, L., Robert, J., Mangeol, A., Branger, C., Petit, J.-C. (2005). Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54: 181-185 [Abstract] [Full Text]  
• Goncalves, C., Decre, D., Barbut, F., Burghoffer, B., Petit, J.-C. (2004). Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile. J. Clin. Microbiol. 42: 1933-1939 [Abstract] [Full Text]  
• Turgeon, D. K., Novicki, T. J., Quick, J., Carlson, L., Miller, P., Ulness, B., Cent, A., Ashley, R., Larson, A., Coyle, M., Limaye, A. P., Cookson, B. T., Fritsche, T. R. (2003). Six Rapid Tests for Direct Detection of Clostridium difficile and Its Toxins in Fecal Samples Compared with the Fibroblast Cytotoxicity Assay. J. Clin. Microbiol. 41: 667-670 [Abstract] [Full Text]  
• Orrhage, K., Sjostedt, S., Nord, C. E. (2000). Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. J Antimicrob Chemother 46: 603-612 [Abstract] [Full Text]  
• Barbut, F., Decré, D., Burghoffer, B., Lesage, D., Delisle, F., Lalande, V., Delmée, M., Avesani, V., Sano, N., Coudert, C., Petit, J.-C. (1999). Antimicrobial Susceptibilities and Serogroups of Clinical Strains of Clostridium difficile Isolated in France in 1991 and 1997. Antimicrob. Agents Chemother. 43: 2607-2611 [Abstract] [Full Text]